BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28704714)

  • 21. Pharmacogenomics of autism spectrum disorder.
    Brown JT; Eum S; Cook EH; Bishop JR
    Pharmacogenomics; 2017 Mar; 18(4):403-414. PubMed ID: 28244813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapeutic approaches in autism spectrum disorders].
    Ruggieri VL; Arberas CL
    Rev Neurol; 2015 Feb; 60 Suppl 1():S45-9. PubMed ID: 25726823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Animal models for autism in 2017 and the consequential implications to drug discovery.
    Chadman KK
    Expert Opin Drug Discov; 2017 Dec; 12(12):1187-1194. PubMed ID: 28971687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetics of Autism Spectrum Disorder.
    Siu MT; Weksberg R
    Adv Exp Med Biol; 2017; 978():63-90. PubMed ID: 28523541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [One autism, several autisms. Phenotypical variability in autism spectrum disorders].
    Hervas A
    Rev Neurol; 2016; 62 Suppl 1():S9-14. PubMed ID: 26922965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autism Spectrum Disorders - Diagnosis and Management.
    Mukherjee SB
    Indian J Pediatr; 2017 Apr; 84(4):307-314. PubMed ID: 28101829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autism spectrum disorder.
    Lord C; Elsabbagh M; Baird G; Veenstra-Vanderweele J
    Lancet; 2018 Aug; 392(10146):508-520. PubMed ID: 30078460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain responses to biological motion predict treatment outcome in young children with autism.
    Yang D; Pelphrey KA; Sukhodolsky DG; Crowley MJ; Dayan E; Dvornek NC; Venkataraman A; Duncan J; Staib L; Ventola P
    Transl Psychiatry; 2016 Nov; 6(11):e948. PubMed ID: 27845779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Converging Psychoanalytic and Neurobiological Understanding of Autism: Promise for Integrative Therapeutic Approaches.
    Giannopoulou I; Lazaratou H; Economou M; Dikeos D
    Psychodyn Psychiatry; 2019; 47(3):275-290. PubMed ID: 31448985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autism Spectrum Disorders: Translating human deficits into mouse behavior.
    Pasciuto E; Borrie SC; Kanellopoulos AK; Santos AR; Cappuyns E; D'Andrea L; Pacini L; Bagni C
    Neurobiol Learn Mem; 2015 Oct; 124():71-87. PubMed ID: 26220900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autism spectrum disorder: Trends in research exploring etiopathogenesis.
    Gyawali S; Patra BN
    Psychiatry Clin Neurosci; 2019 Aug; 73(8):466-475. PubMed ID: 31077508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment Approaches in Rodent Models for Autism Spectrum Disorder.
    Pietropaolo S; Crusio WE; D'amato FR
    Curr Top Behav Neurosci; 2017; 30():325-340. PubMed ID: 26857461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Informant discrepancy defines discrete, clinically useful autism spectrum disorder subgroups.
    Lerner MD; De Los Reyes A; Drabick DAG; Gerber AH; Gadow KD
    J Child Psychol Psychiatry; 2017 Jul; 58(7):829-839. PubMed ID: 28449247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell Therapy Targets for Autism Spectrum Disorders: Hopes, Challenges and Future Directions.
    Larijani B; Foroughi Heravani N; Alavi-Moghadam S; Goodarzi P; Rezaei-Tavirani M; Payab M; Gholami M; Razi F; Arjmand B
    Adv Exp Med Biol; 2021; 1341():107-124. PubMed ID: 32072476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zebrafish models of autism spectrum disorder.
    Meshalkina DA; N Kizlyk M; V Kysil E; Collier AD; Echevarria DJ; Abreu MS; Barcellos LJG; Song C; Warnick JE; Kyzar EJ; Kalueff AV
    Exp Neurol; 2018 Jan; 299(Pt A):207-216. PubMed ID: 28163161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic and Pharmacological Reversibility of Phenotypes in Mouse Models of Autism Spectrum Disorder.
    Schroeder JC; Deliu E; Novarino G; Schmeisser MJ
    Adv Anat Embryol Cell Biol; 2017; 224():189-211. PubMed ID: 28551757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Role of Cholesterol and Fatty Acids in the Etiology and Diagnosis of Autism Spectrum Disorders.
    Esposito CM; Buoli M; Ciappolino V; Agostoni C; Brambilla P
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Educational and Behavioral Interventions in Management of Autism Spectrum Disorder.
    Sengupta K; Lobo L; Krishnamurthy V
    Indian J Pediatr; 2017 Jan; 84(1):61-67. PubMed ID: 26661442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcranial magnetic stimulation in autism spectrum disorder: Challenges, promise, and roadmap for future research.
    Oberman LM; Enticott PG; Casanova MF; Rotenberg A; Pascual-Leone A; McCracken JT;
    Autism Res; 2016 Feb; 9(2):184-203. PubMed ID: 26536383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurotransmitter, Antioxidant and Anti-neuroinflammatory Mechanistic Potentials of Herbal Medicines in Ameliorating Autism Spectrum Disorder.
    Kardani A; Soltani A; Sewell RDE; Shahrani M; Rafieian-Kopaei M
    Curr Pharm Des; 2019; 25(41):4421-4429. PubMed ID: 31721693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.